• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

双重巢式病例对照设计的绝对风险:有和没有扩充估计方程的病因特异性比例风险模型。

Absolute risk from double nested case-control designs: cause-specific proportional hazards models with and without augmented estimating equations.

机构信息

Department of Statistics, Kangwon National University, Chuncheon, Gangwon 24341, South Korea.

Biostatistics Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, MD 20850, United States.

出版信息

Biometrics. 2024 Jul 1;80(3). doi: 10.1093/biomtc/ujae062.

DOI:10.1093/biomtc/ujae062
PMID:38994640
Abstract

We estimate relative hazards and absolute risks (or cumulative incidence or crude risk) under cause-specific proportional hazards models for competing risks from double nested case-control (DNCC) data. In the DNCC design, controls are time-matched not only to cases from the cause of primary interest, but also to cases from competing risks (the phase-two sample). Complete covariate data are available in the phase-two sample, but other cohort members only have information on survival outcomes and some covariates. Design-weighted estimators use inverse sampling probabilities computed from Samuelsen-type calculations for DNCC. To take advantage of additional information available on all cohort members, we augment the estimating equations with a term that is unbiased for zero but improves the efficiency of estimates from the cause-specific proportional hazards model. We establish the asymptotic properties of the proposed estimators, including the estimator of absolute risk, and derive consistent variance estimators. We show that augmented design-weighted estimators are more efficient than design-weighted estimators. Through simulations, we show that the proposed asymptotic methods yield nominal operating characteristics in practical sample sizes. We illustrate the methods using prostate cancer mortality data from the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial Study of the National Cancer Institute.

摘要

我们使用双重嵌套病例对照(DNCC)数据的竞争风险特定比例风险模型来估计相对危险度和绝对风险(或累积发生率或粗风险)。在 DNCC 设计中,对照不仅与主要关注原因的病例时间匹配,而且还与竞争风险(第二阶段样本)的病例时间匹配。第二阶段样本中存在完整的协变量数据,但其他队列成员仅具有生存结果和一些协变量的信息。设计权重估计使用从 Samuelsen 型计算得出的用于 DNCC 的逆抽样概率进行计算。为了利用所有队列成员提供的更多信息,我们使用与竞争风险相关的项来扩展估计方程,该项对零是无偏的,但可以提高特定原因的比例风险模型的估计效率。我们建立了所提出的估计量的渐近性质,包括绝对风险的估计量,并推导出一致的方差估计量。我们表明,扩充的设计权重估计量比设计权重估计量更有效。通过模拟,我们表明在实际样本量下,所提出的渐近方法具有名义操作特性。我们使用美国国立卫生研究院前列腺癌、肺癌、结直肠癌和卵巢癌筛查试验研究中的前列腺癌死亡率数据来说明这些方法。

相似文献

1
Absolute risk from double nested case-control designs: cause-specific proportional hazards models with and without augmented estimating equations.双重巢式病例对照设计的绝对风险:有和没有扩充估计方程的病因特异性比例风险模型。
Biometrics. 2024 Jul 1;80(3). doi: 10.1093/biomtc/ujae062.
2
Lenvatinib plus pembrolizumab for untreated advanced renal cell carcinoma: a systematic review and cost-effectiveness analysis.仑伐替尼联合帕博利珠单抗治疗未经治疗的晚期肾细胞癌:系统评价和成本效果分析。
Health Technol Assess. 2024 Aug;28(49):1-190. doi: 10.3310/TRRM4238.
3
Selenium for preventing cancer.硒预防癌症。
Cochrane Database Syst Rev. 2018 Jan 29;1(1):CD005195. doi: 10.1002/14651858.CD005195.pub4.
4
A rapid and systematic review of the clinical effectiveness and cost-effectiveness of topotecan for ovarian cancer.拓扑替康治疗卵巢癌的临床有效性和成本效益的快速系统评价。
Health Technol Assess. 2001;5(28):1-110. doi: 10.3310/hta5280.
5
Does Augmenting Irradiated Autografts With Free Vascularized Fibula Graft in Patients With Bone Loss From a Malignant Tumor Achieve Union, Function, and Complication Rate Comparably to Patients Without Bone Loss and Augmentation When Reconstructing Intercalary Resections in the Lower Extremity?对于因恶性肿瘤导致骨缺损的患者,在重建下肢节段性切除时,采用带血管游离腓骨移植来增强照射后的自体骨移植,其骨愈合、功能及并发症发生率与无骨缺损且未进行增强的患者相比是否相当?
Clin Orthop Relat Res. 2025 Jun 26. doi: 10.1097/CORR.0000000000003599.
6
A rapid and systematic review of the clinical effectiveness and cost-effectiveness of paclitaxel, docetaxel, gemcitabine and vinorelbine in non-small-cell lung cancer.对紫杉醇、多西他赛、吉西他滨和长春瑞滨在非小细胞肺癌中的临床疗效和成本效益进行的快速系统评价。
Health Technol Assess. 2001;5(32):1-195. doi: 10.3310/hta5320.
7
Corticosteroids for the treatment of Duchenne muscular dystrophy.用于治疗杜氏肌营养不良症的皮质类固醇
Cochrane Database Syst Rev. 2016 May 5;2016(5):CD003725. doi: 10.1002/14651858.CD003725.pub4.
8
Interventions for promoting habitual exercise in people living with and beyond cancer.促进癌症患者及康复者进行习惯性锻炼的干预措施。
Cochrane Database Syst Rev. 2018 Sep 19;9(9):CD010192. doi: 10.1002/14651858.CD010192.pub3.
9
Tobacco packaging design for reducing tobacco use.用于减少烟草使用的烟草包装设计。
Cochrane Database Syst Rev. 2017 Apr 27;4(4):CD011244. doi: 10.1002/14651858.CD011244.pub2.
10
AI-based Hepatic Steatosis Detection and Integrated Hepatic Assessment from Cardiac CT Attenuation Scans Enhances All-cause Mortality Risk Stratification: A Multi-center Study.基于人工智能的心脏CT衰减扫描检测肝脂肪变性及综合肝脏评估可增强全因死亡风险分层:一项多中心研究
medRxiv. 2025 Jun 11:2025.06.09.25329157. doi: 10.1101/2025.06.09.25329157.

本文引用的文献

1
Estimation and inference for semi-competing risks based on data from a nested case-control study.基于嵌套病例对照研究数据的半竞争风险估计与推断。
Stat Methods Med Res. 2020 Nov;29(11):3326-3339. doi: 10.1177/0962280220926219. Epub 2020 Jun 17.
2
Weight calibration to improve the efficiency of pure risk estimates from case-control samples nested in a cohort.体重校准可提高队列嵌套病例对照样本中纯风险估计的效率。
Biometrics. 2020 Dec;76(4):1087-1097. doi: 10.1111/biom.13209. Epub 2020 Jan 2.
3
Estimation of Relative and Absolute Risks in a Competing-Risks Setting Using a Nested Case-Control Study Design: Example From the ProMort Study.
在竞争风险环境下使用嵌套病例对照研究设计估计相对和绝对风险:来自 ProMort 研究的实例。
Am J Epidemiol. 2019 Jun 1;188(6):1165-1173. doi: 10.1093/aje/kwz026.
4
Flexible parametric modelling of cause-specific hazards to estimate cumulative incidence functions.灵活的参数化建模,以估计特定病因的危害,从而估算累积发病函数。
BMC Med Res Methodol. 2013 Feb 6;13:13. doi: 10.1186/1471-2288-13-13.
5
Comparison of estimators in nested case-control studies with multiple outcomes.具有多个结局的巢式病例对照研究中估计量的比较。
Lifetime Data Anal. 2012 Jul;18(3):261-83. doi: 10.1007/s10985-012-9214-8. Epub 2012 Mar 2.
6
Augmented inverse probability weighted estimator for Cox missing covariate regression.用于Cox缺失协变量回归的增强逆概率加权估计器。
Biometrics. 2001 Jun;57(2):414-9. doi: 10.1111/j.0006-341x.2001.00414.x.
7
Prediction of cumulative incidence function under the proportional hazards model.比例风险模型下累积发病率函数的预测
Biometrics. 1998 Mar;54(1):219-28.
8
Estimation of absolute risk from nested case-control data.从巢式病例对照数据估计绝对风险。
Biometrics. 1997 Jun;53(2):767-74.
9
Covariance analysis of censored survival data.删失生存数据的协方差分析
Biometrics. 1974 Mar;30(1):89-99.
10
The analysis of failure times in the presence of competing risks.存在竞争风险时的失效时间分析。
Biometrics. 1978 Dec;34(4):541-54.